Based on continued emergence of bempikibart data from SIGNAL-AA Part A, including strong re-consent rates and patient demand for continued dosing, Company initiating ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DOJoPAWP.js ...

Despite the failure of an eczema trial in December, Q32 Bio is sticking with bempikibart. But a phase 2-stage complement inhibitor and a number of the biotech’s “valued colleagues” won’t be so lucky.

ABU DHABI: The Abu Dhabi Securities Exchange (ADX) continued to solidify its status as a leading financial market regionally and globally in 2024, achieving significant milestones in global rankings, ...

Michael Lee Wood has been in prison for 47 years, serving a life sentence for murder. But that’s only half of the story.

The Identity ADx pacemaker family, which includes the world's smallest dual-chamber pacemaker, provides clinicians with the most advanced pacemaker technology available, including the ...

PureHealth achieved a 58% year-on-year increase in revenue to AED 25.8 billion in FY-2024, reflecting a combination of strong ...

Jan. 28, 2025 — A team of stem cell scientists have successfully used embryonic stem cell engineering to create a bi-paternal mouse -- a mouse with two male parents -- that lived until adulthood.

Oil and gas production, appraisal and exploration.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

After hours: February 7 at 6:17:18 PM EST ...

Feb. 6, 2025 — A recent study investigates how polyester microdroplets, potential precursors to modern cells, could form under realistic early Earth conditions. Researchers pushed these ...